The COPD approval marks the fifth Nucala has received from the FDA, following green lights in severe asthma, chronic rhinosinusitis with nasal polyps, eosinophilic granulomatosis with polyangiitis and ...

The Laredo Public Health Department reports a rise in whooping cough cases and is urging vaccinations to protect infants and ...

Learn the warning signs that differentiate harmless coughs from those requiring medical attention, including timeline ...

Health officials are asking visitors to ensure they are vaccinated against this Victorian-era disease as cases reach an ...

A 26-year-old man’s relentless cough led to a rare diagnosis—psittacosis or parrot fever—caused by inhaling bird droppings ...

We have developed a new, multidimensional diagnostic schema for COPD that incorporates spirometry, symptoms, and imaging and ...

Trevi Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing the investigational therapy Haduviotm (oral nalbuphine ER) for the treatment of chronic cough in patients with ...

Learn about the new COVID-19 JN.1 variant, its symptoms, the level of danger it poses, and vital precautions to stay safe ...

Tezepelumab demonstrated clinically relevant benefits in specific inflammatory subtypes of COPD - an historically underserved market.

A combination of timely interventions now and proactive protocols next winter can benefit patients who experience exacerbated symptoms at certain times of the year.